All Stories

  1. Rebound Thymic Hyperplasia after Recovery from Ectopic Cushing Syndrome: A Case Report and Literature Review
  2. Effects of 12-months treatment with zoledronate or teriparatide on intima-media thickness of carotid artery in women with postmenopausal osteoporosis: A pilot study
  3. Hypothyroidism associated with parathyroid disorders
  4. Epigenetic Alterations in Parathyroid Cancers
  5. Adrenal Ganglioneuroblastoma in Adults: A Case Report and Review of the Literature
  6. Filamin A is reduced and contributes to the CASR sensitivity in human parathyroid tumors
  7. Benign thyroid nodules treatment using percutaneous laser ablation (PLA) and radiofrequency ablation (RFA)
  8. MECHANISMS IN ENDOCRINOLOGY: Kidney involvement in patients with primary hyperparathyroidism: an update on clinical and molecular aspects
  9. Prediction of Vertebral Fractures in Patients With Monolateral Adrenal Incidentalomas
  10. Loss of cells expressing the T-box transcription factor TBX1 might be associated with a quiescent phenotype in parathyroid tumours
  11. Expression and regulation of the early embryonic stem cell genes in parathyroid tumours
  12. JAG1 Loss-Of-Function Variations as a Novel Predisposing Event in the Pathogenesis of Congenital Thyroid Defects
  13. Clinical and molecular heterogeneity in a large series of patients with hypophosphatemic rickets
  14. Molecular and Clinical Aspects of the Target Therapy with the Calcimimetic Cinacalcet in the Treatment of Parathyroid Tumors
  15. Estimated glomerular filtration rate by serum cystatin C correlates with cardiometabolic parameters in patients with primary hyperparathyroidism
  16. Physical activity, dietary habits and cognitive decline in over 65 years Italian outpatients with type 2 diabetes: a cross-sectional pilot study
  17. Gonadal failure is associated with visceral adiposity in myotonic dystrophies
  18. Serum cystatin C levels were correlated with cardiometabolic features and cardiovascular diseases in patients with primary hyperparathyroidism
  19. The Wnt/[beta]-catenin pathway regulates the expression of early embryonic stem cell genes in human parathyroid tumours
  20. miR-372 is aberrantly expressed in most parathyroid tumours and might contribute to parathyroid tumourigenesis by inhibiting CDKN1A/p21 and LATS2
  21. Epigenetic alterations in human parathyroid tumors
  22. Autoimmune Polyendocrine Syndrome 3 Onset with Severe Ketoacidosis in a 74-Year-Old Woman
  23. A Single 60 mg Dose of Denosumab Might Improve Hepatic Insulin Sensitivity in Postmenopausal Nondiabetic Severe Osteoporotic Women
  24. Tumour-associated fibroblasts contribute to neoangiogenesis in human parathyroid neoplasia
  25. Wasting syndrome with deep bradycardia as presenting manifestation of long-standing severe male hypogonadotropic hypogonadism: a case series
  26. Multiple Cerebral Hemorrhagic Foci From Metastases During Temozolomide Treatment in a Patient With Corticotroph Pituitary Carcinoma
  27. Risk of nephrolithiasis in primary hyperparathyroidism is associated with two polymorphisms of the calcium-sensing receptor gene
  28. Factors associated with vertebral fractures in patients with primary hyperparathyroidism
  29. Asymptomatic myotonia congenita unmasked by severe hypothyroidism
  30. PKA regulatory subunit R2B is required for murine and human adipocyte differentiation
  31. An esophageal gastrointestinal stromal tumor in a patient with MEN1-related pancreatic gastrinoma: An unusual association and review of the literature
  32. MIR296 (microRNA 296)
  33. 11. A 23-year-old Woman with Polymenorrhea
  34. Function and origin of tumour-associated fibroblasts (TAFs) in human parathyroid neoplasia
  35. The embryonic transcription factorTBX1is expressed in adult parathyroid cells and might be involved in parathyroid tumorigenesis
  36. CDC73 mutations and parafibromin immunohistochemistry in parathyroid tumors: clinical correlations in a single-centre patient cohort
  37. The microRNA cluster C19MC is deregulated in parathyroid tumours
  38. A rare S33C mutation of CTNNB1 encoding β-catenin in a parathyroid adenoma found in an Italian primary hyperparathyroid cohort
  39. Increased Risk for Non-Autoimmune Hypothyroidism in Young Patients with Congenital Heart Defects
  40. SNPs and real-time quantitative PCR method for constitutional allelic copy number determination, the VPREB1 marker case
  41. Fibrosis is associated with adiponectin resistance in chronic hepatitis C virus infection
  42. Gonadal structures in a fetus with complete androgen insensitivity syndrome and persistent Müllerian derivatives: comparison with normal fetal development
  43. Large Pituitary Hyperplasia in Severe Primary Hypothyroidism
  44. Expression of Parathyroid-Specific Genes in Vascular Endothelial Progenitors of Normal and Tumoral Parathyroid Glands
  45. Sporadic and MEN1-Related Primary Hyperparathyroidism: Differences in Clinical Expression and Severity
  46. Genetic Analysis and Evaluation of Resistance to Thyrotropin and Growth Hormone-Releasing Hormone in Pseudohypoparathyroidism Type Ib
  47. Adipokine levels and cardiovascular risk in patients with adrenal incidentaloma
  48. Maternal and foetal resistin and adiponectin concentrations in normal and complicated pregnancies
  49. Activity and function of the nuclear factor kappaB pathway in human parathyroid tumors
  50. Adiponectin Expression in Human Fetal Tissues during Mid- and Late Gestation
  51. Effect of Recombinant Human Growth Hormone (GH) Replacement on the Hypothalamic-Pituitary-Adrenal Axis in Adult GH-Deficient Patients
  52. Different effects of short- and long-term recombinant hGH administration on ghrelin and adiponectin levels in GH-deficient adults
  53. Parental Origin of Gsα Mutations in the McCune-Albright Syndrome and in Isolated Endocrine Tumors
  54. Rare case of Cushing’s disease due to double ACTH-producing adenomas, one located in the pituitary gland and one into the stalk
  55. Absence of thyroid transcription factor-1 expression in human parathyroid and pituitary glands
  56. Mutation of Somatostatin Receptor Type 5 in an Acromegalic Patient Resistant to Somatostatin Analog Treatment
  57. Expression of Cyclic Adenosine 3′,5′-Monophosphate (cAMP)-Responsive Element Binding Protein and Inducible-cAMP Early Repressor Genes in Growth Hormone-Secreting Pituitary Adenomas with or without Mutations of theGsαGene
  58. Calcium-sensing receptor expression and signalling in human parathyroid adenomas and primary hyperplasia
  59. Expression of Calcium-Sensing Receptor and Characterization of Intracellular Signaling in Human Pituitary Adenomas1
  60. Multiple endocrine neoplasia type 1 in patients with recognized pituitary tumours of different types